Cargando…
Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae
Vaborbactam (formerly RPX7009) is a new beta-lactamase inhibitor based on a cyclic boronic acid pharmacophore. The spectrum of beta-lactamase inhibition by vaborbactam and the impact of bacterial efflux and permeability on its activity were determined using a panel of strains with beta-lactamases cl...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655098/ https://www.ncbi.nlm.nih.gov/pubmed/28848018 http://dx.doi.org/10.1128/AAC.01443-17 |
_version_ | 1783273467896922112 |
---|---|
author | Lomovskaya, Olga Sun, Dongxu Rubio-Aparicio, Debora Nelson, Kirk Tsivkovski, Ruslan Griffith, David C. Dudley, Michael N. |
author_facet | Lomovskaya, Olga Sun, Dongxu Rubio-Aparicio, Debora Nelson, Kirk Tsivkovski, Ruslan Griffith, David C. Dudley, Michael N. |
author_sort | Lomovskaya, Olga |
collection | PubMed |
description | Vaborbactam (formerly RPX7009) is a new beta-lactamase inhibitor based on a cyclic boronic acid pharmacophore. The spectrum of beta-lactamase inhibition by vaborbactam and the impact of bacterial efflux and permeability on its activity were determined using a panel of strains with beta-lactamases cloned from various classes and a panel of Klebsiella pneumoniae carbapenemase 3 (KPC-3)-producing isogenic strains with various combinations of efflux and porin mutations. Vaborbactam is a potent inhibitor of class A carbapenemases, such as KPC, as well as an inhibitor of other class A (CTX-M, SHV, TEM) and class C (P99, MIR, FOX) beta-lactamases. Vaborbactam does not inhibit class D or class B carbapenemases. When combined with meropenem, vaborbactam had the highest potency compared to the potencies of vaborbactam in combination with other antibiotics against strains producing the KPC beta-lactamase. Consistent with broad-spectrum beta-lactamase inhibition, vaborbactam reduced the meropenem MICs for engineered isogenic strains of K. pneumoniae with increased meropenem MICs due to a combination of extended-spectrum beta-lactamase production, class C beta-lactamase production, and reduced permeability due to porin mutations. Vaborbactam crosses the outer membrane of K. pneumoniae using both OmpK35 and OmpK36, but OmpK36 is the preferred porin. Efflux by the multidrug resistance efflux pump AcrAB-TolC had a minimal impact on vaborbactam activity. Investigation of the vaborbactam concentration necessary for restoration of meropenem potency showed that vaborbactam at 8 μg/ml results in meropenem MICs of ≤2 μg/ml in the most resistant engineered strains containing multiple mutations. Vaborbactam is a highly active beta-lactamase inhibitor that restores the activity of meropenem and other beta-lactam antibiotics in beta-lactamase-producing bacteria, particularly KPC-producing carbapenem-resistant Enterobacteriaceae. |
format | Online Article Text |
id | pubmed-5655098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-56550982017-10-30 Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae Lomovskaya, Olga Sun, Dongxu Rubio-Aparicio, Debora Nelson, Kirk Tsivkovski, Ruslan Griffith, David C. Dudley, Michael N. Antimicrob Agents Chemother Mechanisms of Resistance Vaborbactam (formerly RPX7009) is a new beta-lactamase inhibitor based on a cyclic boronic acid pharmacophore. The spectrum of beta-lactamase inhibition by vaborbactam and the impact of bacterial efflux and permeability on its activity were determined using a panel of strains with beta-lactamases cloned from various classes and a panel of Klebsiella pneumoniae carbapenemase 3 (KPC-3)-producing isogenic strains with various combinations of efflux and porin mutations. Vaborbactam is a potent inhibitor of class A carbapenemases, such as KPC, as well as an inhibitor of other class A (CTX-M, SHV, TEM) and class C (P99, MIR, FOX) beta-lactamases. Vaborbactam does not inhibit class D or class B carbapenemases. When combined with meropenem, vaborbactam had the highest potency compared to the potencies of vaborbactam in combination with other antibiotics against strains producing the KPC beta-lactamase. Consistent with broad-spectrum beta-lactamase inhibition, vaborbactam reduced the meropenem MICs for engineered isogenic strains of K. pneumoniae with increased meropenem MICs due to a combination of extended-spectrum beta-lactamase production, class C beta-lactamase production, and reduced permeability due to porin mutations. Vaborbactam crosses the outer membrane of K. pneumoniae using both OmpK35 and OmpK36, but OmpK36 is the preferred porin. Efflux by the multidrug resistance efflux pump AcrAB-TolC had a minimal impact on vaborbactam activity. Investigation of the vaborbactam concentration necessary for restoration of meropenem potency showed that vaborbactam at 8 μg/ml results in meropenem MICs of ≤2 μg/ml in the most resistant engineered strains containing multiple mutations. Vaborbactam is a highly active beta-lactamase inhibitor that restores the activity of meropenem and other beta-lactam antibiotics in beta-lactamase-producing bacteria, particularly KPC-producing carbapenem-resistant Enterobacteriaceae. American Society for Microbiology 2017-10-24 /pmc/articles/PMC5655098/ /pubmed/28848018 http://dx.doi.org/10.1128/AAC.01443-17 Text en Copyright © 2017 Lomovskaya et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Mechanisms of Resistance Lomovskaya, Olga Sun, Dongxu Rubio-Aparicio, Debora Nelson, Kirk Tsivkovski, Ruslan Griffith, David C. Dudley, Michael N. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae |
title | Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae |
title_full | Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae |
title_fullStr | Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae |
title_full_unstemmed | Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae |
title_short | Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae |
title_sort | vaborbactam: spectrum of beta-lactamase inhibition and impact of resistance mechanisms on activity in enterobacteriaceae |
topic | Mechanisms of Resistance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655098/ https://www.ncbi.nlm.nih.gov/pubmed/28848018 http://dx.doi.org/10.1128/AAC.01443-17 |
work_keys_str_mv | AT lomovskayaolga vaborbactamspectrumofbetalactamaseinhibitionandimpactofresistancemechanismsonactivityinenterobacteriaceae AT sundongxu vaborbactamspectrumofbetalactamaseinhibitionandimpactofresistancemechanismsonactivityinenterobacteriaceae AT rubioapariciodebora vaborbactamspectrumofbetalactamaseinhibitionandimpactofresistancemechanismsonactivityinenterobacteriaceae AT nelsonkirk vaborbactamspectrumofbetalactamaseinhibitionandimpactofresistancemechanismsonactivityinenterobacteriaceae AT tsivkovskiruslan vaborbactamspectrumofbetalactamaseinhibitionandimpactofresistancemechanismsonactivityinenterobacteriaceae AT griffithdavidc vaborbactamspectrumofbetalactamaseinhibitionandimpactofresistancemechanismsonactivityinenterobacteriaceae AT dudleymichaeln vaborbactamspectrumofbetalactamaseinhibitionandimpactofresistancemechanismsonactivityinenterobacteriaceae |